Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Differential expression of PAI-RBP1, C1orf142, and COTL1 in non-small cell lung cancer cell lines with different tumor metastatic potential.

Sun W, Guo C, Meng X, Yu Y, Jin Y, Tong D, Geng J, Huang Q, Qi J, Liu A, Guan R, Xu L, Sun D, Ji W, Liu P, Liu F, Sun H, Ji G, Fu S, Bai J.

J Investig Med. 2012 Apr;60(4):689-94. doi: 10.2310/JIM.0b013e31824963b6.

PMID:
22373659
2.
3.

Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.

Su L, Zhang J, Xu H, Wang Y, Chu Y, Liu R, Xiong S.

Clin Cancer Res. 2005 Dec 1;11(23):8273-80.

4.

RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.

Chen H, Yang T, Lei Z, Wang L, Yang H, Tong X, Yang WT, Zhao J, Gu Y, Chen Y, Zhang HT.

Lung Cancer. 2015 Oct;90(1):32-40. doi: 10.1016/j.lungcan.2015.07.010. Epub 2015 Jul 26.

PMID:
26238425
5.

Methylated +58CpG site decreases DCN mRNA expression and enhances TGF-β/Smad signaling in NSCLC cells with high metastatic potential.

Qian Q, Shi X, Lei Z, Zhan L, Liu RY, Zhao J, Yang B, Liu Z, Zhang HT.

Int J Oncol. 2014 Mar;44(3):874-82. doi: 10.3892/ijo.2014.2255. Epub 2014 Jan 10.

PMID:
24424784
6.

[The role of CXCR4 in lung cancer metastasis and its possible mechanism].

Su LP, Zhang JP, Xu HB, Chen J, Wang Y, Xiong SD.

Zhonghua Yi Xue Za Zhi. 2005 May 11;85(17):1190-4. Chinese.

PMID:
16029594
7.

[miR-610 suppresses lung cancer cell proliferation and invasion by targeting GJA3].

Jin J, Li C, You J, Zhang B.

Zhonghua Zhong Liu Za Zhi. 2014 Jun;36(6):405-11. Chinese.

PMID:
25241780
8.

Posttranslational modification of E-cadherin by core fucosylation regulates Src activation and induces epithelial-mesenchymal transition-like process in lung cancer cells.

Shao K, Chen ZY, Gautam S, Deng NH, Zhou Y, Wu XZ.

Glycobiology. 2016 Feb;26(2):142-54. doi: 10.1093/glycob/cwv089. Epub 2015 Oct 6.

PMID:
26443198
9.

Differential expression of Dickkopf-1 among non-small cell lung cancer cells.

Xiang XJ, Liu YW, Chen DD, Yu S.

Mol Med Rep. 2015 Aug;12(2):1935-40. doi: 10.3892/mmr.2015.3654. Epub 2015 Apr 21.

PMID:
25901391
10.

[Correlative study between expression of BRI gene and metastatic potential in human non-small cell lung cancer].

Chen YZ, Li Y, Zou R, Chen Y, Wang YY, Feng HC, Wang WR.

Zhonghua Bing Li Xue Za Zhi. 2004 Feb;33(1):62-6. Chinese.

PMID:
14989933
11.

The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer.

Zequn N, Xuemei Z, Wei L, Zongjuan M, Yujie Z, Yanli H, Yuping Z, Xia M, Wei W, Wenjing D, Na F, Shuanying Y.

Oncotarget. 2016 Apr 5;7(14):18219-28. doi: 10.18632/oncotarget.7788.

12.

The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.

Chen WL, Kuo KT, Chou TY, Chen CL, Wang CH, Wei YH, Wang LS.

BMC Cancer. 2012 Jun 29;12:273. doi: 10.1186/1471-2407-12-273.

13.

Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.

Koensgen D, Mustea A, Klaman I, Sun P, Zafrakas M, Lichtenegger W, Denkert C, Dahl E, Sehouli J.

Gynecol Oncol. 2007 Nov;107(2):266-73. Epub 2007 Aug 14.

PMID:
17698176
14.

Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.

Jakowlew SB, Mariano JM, You L.

Growth Factors. 1997;14(2-3):177-97.

PMID:
9255608
15.

DJ-1 may contribute to metastasis of non-small cell lung cancer.

Bai J, Guo C, Sun W, Li M, Meng X, Yu Y, Jin Y, Tong D, Geng J, Huang Q, Qi J, Fu S.

Mol Biol Rep. 2012 Mar;39(3):2697-703. doi: 10.1007/s11033-011-1024-7. Epub 2011 Jun 14.

PMID:
21670963
16.

Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer.

Zhu X, Guo Y, Li X, Ding Y, Chen L.

J Thorac Oncol. 2010 Aug;5(8):1159-66. doi: 10.1097/JTO.0b013e3181e04d98.

17.

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.

Dai SD, Wang Y, Miao Y, Zhao Y, Zhang Y, Jiang GY, Zhang PX, Yang ZQ, Wang EH.

BMC Cancer. 2009 Jun 9;9:178. doi: 10.1186/1471-2407-9-178.

18.

Overexpression of LCMR1 is significantly associated with clinical stage in human NSCLC.

Chen L, Liang Z, Tian Q, Li C, Ma X, Zhang Y, Yang Z, Wang P, Li Y.

J Exp Clin Cancer Res. 2011 Feb 9;30:18. doi: 10.1186/1756-9966-30-18.

19.

Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.

Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.

Lung Cancer. 2008 Oct;62(1):113-9. doi: 10.1016/j.lungcan.2008.02.014. Epub 2008 Jun 11.

PMID:
18550205
20.

Transcriptional regulation of urokinase receptor in high- (95D) and low-metastatic (95C) human lung cancer cells.

Li CY, Tan L, Zhang GJ, Li P, Tong C, Fan J, Zhu YS.

Acta Biochim Biophys Sin (Shanghai). 2004 Jun;36(6):405-11.

PMID:
15188055

Supplemental Content

Support Center